Description
Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
Product information
CAS Number: 84629-61-8
Molecular Weight: 347.41
Formula: C21H21N3O2
Chemical Name: (2E)-2-[2-(4-methylpiperazin-1-yl)-2-oxoethylidene]-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
Smiles: CN1CCN(CC1)C(=O)/C=C1\C2=CC=CC=C2C(=O)NC2=CC=CC=C\12
InChiKey: VBQROPPRMFZXNC-NBVRZTHBSA-N
InChi: InChI=1S/C21H21N3O2/c1-23-10-12-24(13-11-23)20(25)14-18-15-6-2-3-8-17(15)21(26)22-19-9-5-4-7-16(18)19/h2-9,14H,10-13H2,1H3,(H,22,26)/b18-14+
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.